![JPM | Free Full-Text | NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series JPM | Free Full-Text | NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series](https://pub.mdpi-res.com/jpm/jpm-12-01819/article_deploy/html/images/jpm-12-01819-ag.png?1667643911)
JPM | Free Full-Text | NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series
![Frontiers | Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source Frontiers | Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source](https://www.frontiersin.org/files/Articles/573406/fimmu-11-573406-HTML-r1/image_m/fimmu-11-573406-g001.jpg)
Frontiers | Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source
![Epstein–Barr virus-associated lymphomas | Philosophical Transactions of the Royal Society B: Biological Sciences Epstein–Barr virus-associated lymphomas | Philosophical Transactions of the Royal Society B: Biological Sciences](https://royalsocietypublishing.org/cms/asset/7ff7300f-b8a4-43f0-9ac4-74a508e2d069/rstb.372.issue-1732.largecover.jpeg)
Epstein–Barr virus-associated lymphomas | Philosophical Transactions of the Royal Society B: Biological Sciences
![Cancers | Free Full-Text | A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells Cancers | Free Full-Text | A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells](https://www.mdpi.com/cancers/cancers-14-04558/article_deploy/html/images/cancers-14-04558-g001-550.jpg)
Cancers | Free Full-Text | A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells
![IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aav3942/asset/88282133-31f0-4870-8527-5149029af535/assets/graphic/aav3942-f2.jpeg)